Innehållet på denna webbplats är endast avsett för veterinärer eller andra professionella inom djurhälsovård.
Genom att använda denna webbplats accepterar du ovanstående.
Intervacc AB (publ) publishes prospectus regarding the rights issue
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER...Report from Extraordinary General Meeting in Intervacc
Intervacc AB (publ) held an Extraordinary General Meeting (”EGM”) on Friday 31 January 2025, whereby it was resolved to approve the Board of Directors’ proposal to amend the Articles of Association and to approve the Board of Directors’ resolution on a rights issue....Intervacc has received orders from Dechra Pharmaceuticals with an order value equivalent to approximately SEK 5.8 million
Stockholm, January 16, 2025 – Intervacc AB (publ) has received orders from Dechra Pharmaceuticals with a total order value equivalent to approximately SEK 5.8 million. Orders received relate to Strangvac®, a vaccine against the highly contagious and serious...Notice of Extraordinary General Meeting in Intervacc AB (publ)
The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Extraordinary General Meeting (“EGM”) to be held on Friday 31 January 2025 at 3.00 p.m. at Cirio Advokatbyrå, Biblioteksgatan 9, in Stockholm. The Board of...The Board of Directors of Intervacc resolves on a rights issue of approximately SEK 225 million
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER...Nyhetstjänster
